{"disease":{"id":"keratosis","name":"keratosis"},"drugs":{"marketed":[{"drug_id":"5-fu","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carac","generic_name":"5-fu","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"Nucleoside Metabolic Inhibitor","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"diclofenac","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Voltaren","generic_name":"DICLOFENAC","company_name":"Hisamitsu Pharmaceutical Co., Inc","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"Nonsteroidal Anti-inflammatory Drug","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"tirbanibulin","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Klisyri","generic_name":"TIRBANIBULIN","company_name":"Almirall","drug_phase":"marketed","molecular_target":"Tyrosine-protein kinase Lyn","drug_class":"Microtubule Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":"Klisyri works by disrupting the microtubule network, which is essential for cell division."},{"drug_id":"picato","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Picato","company_name":"LEO Pharma","drug_phase":"discontinued","molecular_target":"Protein kinase C alpha type, Protein kinase C epsilon type, Protein kinase C gamma type","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"tretinoin","indication_name":"Hyperkeratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Retin-A","generic_name":"TRETINOIN","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Nuclear receptor ROR-beta","drug_class":"Retinoid [EPC]","quality_score":58,"revenue":null,"mechanism":"Tretinoin works by binding to and activating nuclear receptors, which helps to regulate cell growth and differentiation."},{"drug_id":"ingenol-mebutate","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Picato","generic_name":"INGENOL MEBUTATE","company_name":"Leo Labs","drug_phase":"marketed","molecular_target":"Protein kinase C alpha type, Protein kinase C epsilon type, Protein kinase C gamma type","drug_class":"","quality_score":17,"revenue":null,"mechanism":null},{"drug_id":"fluorouracil","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carac","generic_name":"fluorouracil","company_name":"Extrovis","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"arthrotec","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arthrotec","generic_name":"Diclofenac Sodium","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Acid-sensing ion channel 3","drug_class":"diclofenac","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"masoprocol","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Actinex","generic_name":"MASOPROCOL","company_name":"","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"masoprocol","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"aminolevulinic-acid","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Levulan","generic_name":"AMINOLEVULINIC ACID","company_name":"Sun Pharma","drug_phase":"marketed","molecular_target":"","drug_class":"Optical Imaging Agent","quality_score":70,"revenue":null,"mechanism":"Levulan accumulates in abnormal skin cells, allowing for visualization and treatment."},{"drug_id":"imiquimod","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldara","generic_name":"IMIQUIMOD","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"7,8-dihydro-8-oxoguanine triphosphatase","drug_class":"imiquimod","quality_score":75,"revenue":null,"mechanism":"Aldara works by activating the immune system to recognize and attack abnormal cells."},{"drug_id":"ameluz","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ameluz","company_name":"Sherrif Ibrahim","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"gliolan","indication_name":"Actinic keratosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Gliolan","company_name":"Abramson Cancer Center at Penn Medicine","drug_phase":"phase_2","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":13,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06535867","title":"The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study","phase":"","overall_status":"RECRUITING","enrollment_count":5122,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04327622","title":"Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population","phase":"","overall_status":"COMPLETED","enrollment_count":5084,"lead_sponsor_name":"LMC Diabetes & Endocrinology Ltd.","has_results":false},{"nct_id":"NCT00027274","title":"Cancer in Inherited Bone Marrow Failure Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03050268","title":"Familial Investigations of Childhood Cancer Predisposition","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT06206681","title":"Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT02952898","title":"Study Comparing GDC 695 and Diclofenac Sodium Gel, 3% in Subjects With Actinic Keratoses","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":665,"lead_sponsor_name":"Balmoral Medical company","has_results":true},{"nct_id":"NCT04552327","title":"5% KOH Solution vs. Placebo and Diclofenac Gel for the Treatment of Actinic Keratosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":631,"lead_sponsor_name":"Infectopharm Arzneimittel GmbH","has_results":false},{"nct_id":"NCT03115476","title":"A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":563,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT03200912","title":"An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":507,"lead_sponsor_name":"Actavis Inc.","has_results":true},{"nct_id":"NCT01926496","title":"Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":485,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT02120898","title":"A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":467,"lead_sponsor_name":"Actavis Inc.","has_results":true},{"nct_id":"NCT03727074","title":"Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":462,"lead_sponsor_name":"Sol-Gel Technologies, Ltd.","has_results":false},{"nct_id":"NCT02616601","title":"Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":422,"lead_sponsor_name":"Actavis Inc.","has_results":true},{"nct_id":"NCT02549339","title":"Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":383,"lead_sponsor_name":"LEO Pharma","has_results":true},{"nct_id":"NCT03285490","title":"A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":351,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT05741294","title":"A Study of Tirbanibulin on the Wellbeing of Participants With Actinic Keratoses","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":334,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT05260073","title":"Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT06135415","title":"A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":280,"lead_sponsor_name":"Almirall, S.A.","has_results":false},{"nct_id":"NCT03148691","title":"A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":253,"lead_sponsor_name":"Aclaris Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03116698","title":"A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Dr. Reddy's Laboratories Limited","has_results":true},{"nct_id":"NCT05942794","title":"Identification of Oral Lesions Through an Autofluorescence System","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Federico II University","has_results":false},{"nct_id":"NCT04249115","title":"Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study","phase":"NA","overall_status":"TERMINATED","enrollment_count":175,"lead_sponsor_name":"Pulse Biosciences, Inc.","has_results":false},{"nct_id":"NCT07384299","title":"Impact of Skin Type on Wonud Healing and Scarring Following Facial Skin Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":173,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT02838628","title":"Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT06046144","title":"Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors","phase":"","overall_status":"COMPLETED","enrollment_count":161,"lead_sponsor_name":"Centre Hospitalier Universitaire de Saint Etienne","has_results":false},{"nct_id":"NCT07441538","title":"Optimizing the Timing for Facial Surgical Dressing Removal","phase":"NA","overall_status":"COMPLETED","enrollment_count":144,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT03319251","title":"Biomarker Database Registry for Photodynamic Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":137,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT00304239","title":"Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT04269395","title":"A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":125,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT05060237","title":"Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Biofrontera Bioscience GmbH","has_results":true},{"nct_id":"NCT05231044","title":"A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"PharmaEssentia","has_results":false},{"nct_id":"NCT05279131","title":"A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Almirall, S.A.","has_results":true},{"nct_id":"NCT02844777","title":"Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Vidac Pharma","has_results":true},{"nct_id":"NCT03447925","title":"Treatment of Plantar Keratosis With Medicinal Plant in Diabetic Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Universidade do Vale do Sapucai","has_results":false},{"nct_id":"NCT03538951","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Vidac Pharma","has_results":true},{"nct_id":"NCT00472459","title":"Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Galderma R&D","has_results":true},{"nct_id":"NCT02404389","title":"Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07095348","title":"Relationship Between Serum Xanthine Oxidase Levels and Seborrheic Keratosis","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Sri Nauli Dewi Lubis","has_results":false},{"nct_id":"NCT04140292","title":"Vitamin D Supplementation as a Neoadjuvant for Photodynamic Therapy of Actinic Keratoses","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":true},{"nct_id":"NCT06014697","title":"OCT and Invasion in Cutaneous Skin Lesions","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT05136144","title":"Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"DermBiont, Inc.","has_results":false},{"nct_id":"NCT02162420","title":"Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":true},{"nct_id":"NCT05636800","title":"Microwave Treatment for Actinic Keratosis","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Blackwell Device Consulting","has_results":false},{"nct_id":"NCT06108024","title":"A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"DermBiont, Inc.","has_results":false},{"nct_id":"NCT03037541","title":"Cryosurgery and Cream Combination for Actinic Keratosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT07273656","title":"Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":59,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT03846531","title":"Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Pulse Biosciences, Inc.","has_results":true},{"nct_id":"NCT05699603","title":"Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":56,"lead_sponsor_name":"University of Arizona","has_results":false},{"nct_id":"NCT07290959","title":"Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK","phase":"NA","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"San Salvatore Hospital of L'Aquila","has_results":false},{"nct_id":"NCT04959188","title":"Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)","phase":"","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}